FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Calendar & Events

Presentation at Øknomiske Ugebrev "Life Science Investor" konference in Copenhagen

20 October 2021, 

Read more

Presentation at Redeye Life Science Day

11 November 2021

Read more

January - September 2021 (Q3)

24 November 2021

Target release time before 9.00 AM

SEB Nordic Seminar 2022 in Copenhagen

12 January 2022

SEB Nordic Healthcare Seminar in Stockholm

18- 19 January 2022